Sun Pharma shares up 3%; m-cap rises by ~3,260 cr

Business Standard - - THE SMART INVESTOR -

Shares of Sun Phar­ma­ceu­ti­cal In­dus­tries on Thurs­day rose by nearly 3 per cent, adding ~3,260 crore to its mar­ket val­u­a­tion, af­ter the com­pany re­ceived es­tab­lish­ment in­spec­tion re­port (EIR) from the US health reg­u­la­tor for its Dadra fa­cil­ity. The stock went up by 2.59 per cent to set­tle at ~539.40 on the BSE. Dur­ing the day, it ad­vanced by 4.22 per cent to ~548. At NSE, shares of the com­pany climbed 2.56 per cent to close at ~539.55. The com­pany's mar­ket val­u­a­tion rose by ~3,260 crore to ~1,29,415 crore. PTI<

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.